Press Release

Protein Discovery Inc. Receives 2005 Federal Laboratory Consortium Award for Excellence in Technology Transfer

Knoxville, Tennessee, June 1, 2005—Protein Discovery, Inc., a privately held life sciences company, today announced it has received the prestigious 2005 Award for Excellence in Technology Transfer from the Federal Laboratory Consortium (FLC), an organization chartered by the US Congress to facilitate the movement of federal laboratory research results into the mainstream of the US economy. This award recognizes the outstanding collaborative work between Protein Discovery, Inc. and the Oak Ridge National Laboratory (ORNL) in transferring technology developed in a federal laboratory to the commercial marketplace.

In a letter announcing the award addressed to Chuck Witkowski, president and chief executive officer of Protein Discovery, Inc., US secretary of energy Samuel W. Bodeman wrote, “In particular, I would like to recognize your contribution toward the successful partnering efforts for The Photo-Molecular Comb™ Biomolecule Separator that can separate proteins and other biomolecules for identification and analysis. This technology allows scientists and clinicians to simultaneously detect and monitor thousands of disease markers in contrast to existing diagnostics that measure these markers one at a time.”

“We’re delighted to have been chosen by the FLC to receive the 2005 Award for Excellence in Technology Transfer,” said Witkowski. “This award reflects our focused effort and successful progress in making the strategic transition from product development to product commercialization.”

About Protein Discovery, Inc.
Protein Discovery, Inc. is a venture capital-backed life sciences company developing solutions for biomarker discovery and analysis. The company’s technology addresses many of the key challenges facing biomarker discovery, including speed, data quality, and the complexity of serum and other biological samples. The ability to reproducibly identify and quantify suites of clinically significant biomarkers in a high-throughput fashion will enhance patient health by improving the diagnosis, prognosis, and treatment of disease. For additional information, please visit www.proteindiscovery.com.

TOP